COAGULATION CASCADE
The coagulation cascade is a complex series of events that prevents excessive bleeding and promotes wound healing. It involves a sequence of tightly regulated steps, categorized into three main phases: initiation, amplification, and propagation.
Initiation:
The process begins with vascular injury, exposing tissue factor (TF) at the site of damage.
TF forms a complex with factor VII, activating it and initiating the extrinsic pathway.
Amplification:
The intrinsic pathway is activated simultaneously through factors XII, XI, IX, and VIII.
Platelets adhere to the exposed collagen, releasing chemicals that attract more platelets to the site.
Thrombin, a crucial enzyme in clot formation, is generated, further stimulating platelet activation and aggregation.
Propagation:
Thrombin activates factors V, VIII, and XI, amplifying the coagulation response.
Fibrin, the mesh-like structure of the clot, is formed by the action of thrombin on fibrinogen.
The stable clot contracts to reduce the wound size and promote tissue repair.
Regulation:
Anticoagulant mechanisms, such as antithrombin III, protein C, and protein S, counterbalance coagulation to prevent excessive clotting.
Fibrinolysis dissolves the clot once healing is underway, facilitated by plasminogen activation.
Clinical Implications:
Disorders in the coagulation cascade can lead to bleeding disorders (hemophilia) or thrombotic conditions (deep vein thrombosis).
Medications, such as anticoagulants and antiplatelet drugs, target specific points in the cascade to manage clotting disorders.
Message ChatGPT…
Senior Market Research Expert at The Insight Partners
1 年?????????????????????? ???????????? ???????????????? ???????????? | ???????????? ???????? & ?????????? ???????? The coagulation market is expected to grow from US$ 6,295.28 million in 2022 to US$ 10,853.28 million by 2030; it is anticipated to record a?CAGR of 7.0% from 2022 to 2030. ???????? ????????-? https://www.theinsightpartners.com/reports/coagulation-market